BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19965574)

  • 21. CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.
    Nahlé Z; Hsieh M; Pietka T; Coburn CT; Grimaldi PA; Zhang MQ; Das D; Abumrad NA
    J Biol Chem; 2008 May; 283(21):14317-26. PubMed ID: 18308721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor alpha-retinoid X receptor agonists induce beta-cell protection against palmitate toxicity.
    Hellemans K; Kerckhofs K; Hannaert JC; Martens G; Van Veldhoven P; Pipeleers D
    FEBS J; 2007 Dec; 274(23):6094-105. PubMed ID: 17970749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into pancreatic β-cell glucolipotoxicity from real-time functional analysis of mitochondrial energy metabolism in INS-1E insulinoma cells.
    Barlow J; Affourtit C
    Biochem J; 2013 Dec; 456(3):417-26. PubMed ID: 24099598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
    Xie T; So WY; Li XY; Leung PS
    Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.
    Boergesen M; Poulsen Ll; Schmidt SF; Frigerio F; Maechler P; Mandrup S
    J Biol Chem; 2011 Apr; 286(15):13214-25. PubMed ID: 21282101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
    Dimopoulos N; Watson M; Green C; Hundal HS
    FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism.
    Frigerio F; Brun T; Bartley C; Usardi A; Bosco D; Ravnskjaer K; Mandrup S; Maechler P
    Diabetologia; 2010 Feb; 53(2):331-40. PubMed ID: 19908022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity.
    Li J; Liu X; Ran X; Chen J; Li X; Wu W; Huang H; Huang H; Long Y; Liang J; Cheng J; Tian H
    Diabetes Obes Metab; 2010 Jan; 12(1):35-46. PubMed ID: 19758361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of PPARδ up-regulates the expression of insulin gene transcription factor MafA and ameliorates glucose-induced insulin secretion impaired by palmitate.
    Cao M; Long Y; Tong Y; Wan J; Tong N
    Mol Cell Biochem; 2012 Jul; 366(1-2):183-9. PubMed ID: 22466807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids.
    de Lange P; Feola A; Ragni M; Senese R; Moreno M; Lombardi A; Silvestri E; Amat R; Villarroya F; Goglia F; Lanni A
    Endocrinology; 2007 Aug; 148(8):4064-72. PubMed ID: 17478558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate.
    Frigerio F; Chaffard G; Berwaer M; Maechler P
    Biochem Pharmacol; 2006 Oct; 72(8):965-73. PubMed ID: 16934763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db mice.
    Winzell MS; Wulff EM; Olsen GS; Sauerberg P; Gotfredsen CF; Ahrén B
    Eur J Pharmacol; 2010 Jan; 626(2-3):297-305. PubMed ID: 19818749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-inflammatory cytokines attenuate glucose-stimulated insulin secretion from INS-1E insulinoma cells by restricting mitochondrial pyruvate oxidation capacity - Novel mechanistic insight from real-time analysis of oxidative phosphorylation.
    Barlow J; Solomon TPJ; Affourtit C
    PLoS One; 2018; 13(6):e0199505. PubMed ID: 29953508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor δ improves porcine blastocyst hatching via the regulation of fatty acid oxidation.
    Guo J; Lu WF; Liang S; Choi JW; Kim NH; Cui XS
    Theriogenology; 2017 Mar; 90():266-275. PubMed ID: 28166979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation.
    Cohen G; Shamni O; Avrahami Y; Cohen O; Broner EC; Filippov-Levy N; Chatgilialoglu C; Ferreri C; Kaiser N; Sasson S
    Diabetologia; 2015 Jun; 58(6):1333-43. PubMed ID: 25810039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of peroxisome proliferator-activated receptor δ (PPARδ) by digoxin to improve lipid metabolism in the heart of diabetic rats.
    Chen ZC; Yu BC; Chen LJ; Cheng JT
    Horm Metab Res; 2013 May; 45(5):364-71. PubMed ID: 23225238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oleic acid protects insulin-secreting INS-1E cells against palmitic acid-induced lipotoxicity along with an amelioration of ER stress.
    Liu X; Zeng X; Chen X; Luo R; Li L; Wang C; Liu J; Cheng J; Lu Y; Chen Y
    Endocrine; 2019 Jun; 64(3):512-524. PubMed ID: 30778898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term exposure of INS-1 rat insulinoma cells to linoleic acid and glucose in vitro affects cell viability and function through mitochondrial-mediated pathways.
    Tuo Y; Wang D; Li S; Chen C
    Endocrine; 2011 Apr; 39(2):128-38. PubMed ID: 21161439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism.
    Ronnebaum SM; Joseph JW; Ilkayeva O; Burgess SC; Lu D; Becker TC; Sherry AD; Newgard CB
    J Biol Chem; 2008 May; 283(21):14248-56. PubMed ID: 18381287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.